Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: involvement of HMGB1 in anti-DNA antibody-induced renal injury.
Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: involvement of HMGB1 in anti-DNA antibody-induced renal injury.
复制标题
DOI:
10.1016/j.imlet.2008.08.007
复制
发表时间:
2008-11-16
影响因子:
4.4
通讯作者:
Putterman, Chaim
中科院分区:
文献类型:
--
作者:
Qing, Xiaoping;Pitashny, Milena;Thomas, David B.;Barrat, Franck J.;Hogarth, Mark P.;Putterman, Chaim
Although anti-DNA antibodies have been decisively linked to the pathogenesis of lupus nephritis, the mechanisms have not been conclusively determined. Recently, we reported that anti-DNA antibodies may contribute to kidney damage by upregulation of proinflammatory genes in mesangial cells (MC), a process involving both Fc receptor dependent and independent pathways. In investigating the mechanism by which pathogenic anti-DNA antibodies modulate gene expression in MC, we found that the pathogenic anti-DNA antibody 1A3F bound to high mobility group binding protein 1 (HMGB1), an endogenous ligand for TLR2/4 and RAGE (receptor for advanced glycation end-products). Interestingly, HMGB1 treatment of MC induced a similar pattern of genes as stimulation with 1A3F. Furthermore, HMGB1 and 1A3F exhibited a synergistic proinflammatory effect in the kidney, where increased expression of HMGB1 was found in lupus patients but not in patients with other types of renal disease. TLR2/Fc and RAGE/Fc inhibited the proinflammatory effects of 1A3F on MC. Finally, we found enhanced susceptibility of lupus prone MRL-lpr/lpr (MRL/lpr) as compared to normal BALB/c derived MC to pathogenic anti-DNA antibody and LPS stimulation (in particular enhanced chemokine synthesis), in addition to significantly increased expression of TLR4. Our results suggest that gene upregulation in MC induced by nephritogenic anti-DNA antibodies is TLR2/4 and RAGE dependent. Finally, HMGB1 may act as a proinflammatory mediator in antibody induced kidney damage in systemic lupus erythematosus (SLE).
登录
查看更多内容
影响因子:
15.9
作者:
EMLEN, W;ANSARI, R;BURDICK, G
通讯作者:
BURDICK, G
影响因子:
4.4
作者:
Deocharan, B;Qing, XP;Putterman, C
通讯作者:
Putterman, C
影响因子:
2.6
作者:
Barkauskaite, V.;Ek, M.;Nyberg, F.
通讯作者:
Nyberg, F.
影响因子:
4.4
作者:
Fu, YY;Xie, C;Mohan, C
通讯作者:
Mohan, C
DOI:
10.1084/jem.20030132
发表时间:
2004-02-02
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Liang Z;Xie C;Chen C;Kreska D;Hsu K;Li L;Zhou XJ;Mohan C
通讯作者:
Mohan C